Proven businesses. Overlooked prices.

I write independent research on small- and micro-cap companies outside the US, drawing on my experience as a professional investor in private and public equity. I aim to publish one research piece a week.

The focus is on understandable businesses with long operating histories, attractive valuations and a credible path to shareholder returns through cash generation and distributions. Strong prospective growth is welcome, but not a prerequisite.

I follow opportunities across markets outside the US. Given where I currently see value, I expect much of the initial research to cover companies listed in Japan, Korea, Hong Kong, Taiwan and Malaysia.

Many will be lightly researched and thinly traded—typically with average daily trading value of US$10,000–200,000. Limited liquidity keeps larger institutional investors away and creates opportunities for patient investors.

My research centres on published information and long-term financial analysis. Management interviews and activism are not central to the process, although I have professional experience with both. I favour investments whose returns do not depend on substantial governance changes.

Short-term or date-specific catalysts are not important to me. I invest in companies where I see a path to attractive risk-adjusted returns even if we have to wait.

My background research and financial data clean-up is AI-assisted, but all executive summaries, valuation commentary and potential return discussions are entirely my own words.

Why I publish

The research is free. I publish for three reasons:

  1. I enjoy learning about businesses, analysing their financials and sharing my conclusions.

  2. Companies of this kind make up the majority of my family portfolio, so understanding them matters directly to me.

  3. Publishing creates a dated record of my investment ideas and the reasoning behind them.

I expect to own many of the companies discussed when I write about them. My holdings may change, and I do not undertake to announce every purchase or sale.

Join the discussion

Constructive criticism, differing views and your own investment ideas are welcome. If you find the research useful, I hope you will contribute to the discussion—particularly when you think I have missed something.

Reply to an email or leave a comment on a post.

Thank you for reading,
Uncrowded Value

Research is for information only and is not personalised investment advice. Please do your own due diligence.

Why subscribe?

Subscribe to get full access to the newsletter and publication archives.

Stay up-to-date

Never miss an update—every new post is sent directly to your email inbox. For a spam-free, ad-free reading experience, plus audio and community features, get the Substack app.

Join the crew

Be part of a community of people who share your interests. Participate in the comments section, or support this work with a subscription.

To learn more about the tech platform that powers this publication, visit Substack.com.

User's avatar

Subscribe to Uncrowded Value

Proven businesses. Overlooked prices. Independent stock research focused on small- and micro-cap companies outside the US, by a former professional investor in private and public equity.

People

x